CV Sciences partners with the Rodale Institute on organic and industrial hemp research

CV Sciences Inc (OCTQB:CVSI) said on Tuesday the company is sponsoring Rodale Institute’s research on organic hemp farming along with industry leaders Patagonia and Dr Bronner’s.

Joseph Dowling, the CEO at CV Sciences, said in a statement the research should help “increase organic production of hemp.”

“We believe that hemp can play a large role in the future of agriculture and look forward to working with Rodale to further organic hemp production,” he added.

The Rodale Institute is the nation’s leading organic farming institution, dedicated to pioneering organic farming through research and outreach.

The company continues to invest and support the promising future of agricultural hemp in the United States and the partnership with the Rodale Institute demonstrates a commitment to expanding scientific research in hemp agriculture.

READ: CV Sciences determines its hemp-derived CBD extract meets FDA safety standards

Since 2014, CV Sciences has pioneered the hemp industry through research and development affiliations with the University of Kentucky and Murray State University, amongst others. 

“We appreciate the support of CV Sciences as we explore hemp’s role in soil health,” said Jeff Moyer, executive director of the Rodale Institute. 

Shares of CV Sciences were down 6.44% at $5.52 in late trade on Tuesday.

CV Sciences operates two business segments. One is a drug development division focused on developing and commercializing novel therapeutics utilizing synthetic CBD.

The other is a consumer product division focused on manufacturing, marketing and selling plant-based CBD products.

The company is based in Henderson, Nevada.

Reporting by Rene Pastor, contactable on [email protected]

Story by ProactiveInvestors